Jie Qian, Ph.D.
Affiliations: | 2008 | University of Virginia, Charlottesville, VA |
Area:
Analytical BiochemistryGoogle:
"Jie Qian"Mean distance: 8.97 | S | N | B | C | P |
Parents
Sign in to add mentor| Donald F. Hunt | grad student | 2008 | UVA | |
| (Identification of class I and II MHC peptides as targets for immunotherapy using mass spectrometry.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Qian J, Yu X, Liu Z, et al. (2023) SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine. Frontiers in Immunology. 14: 1118781 |
| Nie W, Xu MD, Gan L, et al. (2020) Advanced Non-Small Cell Lung Cancer Patients With Low Tumor Mutation Burden Might Derive Benefit From Immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997) |
| Liu Y, Zhou S, Qian J, et al. (2017) T-bet(+)CD11c(+) B cells are critical for antichromatin immunoglobulin G production in the development of lupus. Arthritis Research & Therapy. 19: 225 |
| Zhang L, Bi E, Hong S, et al. (2015) CD4+ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma. Oncotarget |
| Lin XB, Jiang L, Ding MH, et al. (2015) Anti-tumor activity of phenoxybenzamine hydrochloride on malignant glioma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine |
| Cobbold M, De La Peña H, Norris A, et al. (2013) MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Science Translational Medicine. 5: 203ra125 |
| Yu X, Guo C, Yi H, et al. (2013) A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity. Cancer Research. 73: 2093-103 |
| Guo C, Yi H, Yu X, et al. (2012) In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer. Molecular Cancer Therapeutics. 11: 2331-41 |
| Yi H, Guo C, Yu X, et al. (2011) Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity. Cancer Research. 71: 6611-20 |
| Qian J, Yi H, Guo C, et al. (2011) CD204 suppresses large heat shock protein-facilitated priming of tumor antigen gp100-specific T cells and chaperone vaccine activity against mouse melanoma. Journal of Immunology (Baltimore, Md. : 1950). 187: 2905-14 |